The public health control of scabies: priorities for research and action

Simple item page
dc.contributor.authorPhillips, Richard Odame
dc.contributor.authorStienstra, Ymkje
dc.contributor.authorBeeres, Dorien T
dc.contributor.authorVonk, Machiel
dc.contributor.authorRavensbergen, Sofanne J
dc.date.accessioned2020-01-13T13:01:35Z
dc.date.accessioned2023-04-19T01:48:15Z
dc.date.available2020-01-13T13:01:35Z
dc.date.available2023-04-19T01:48:15Z
dc.date.issued2019-12-07
dc.descriptionAn article published by The Lanceten_US
dc.description.abstractWe read the Article by David Engelman and colleagues1 with interest. Their overview of the key operational research questions to develop a global control programme for scabies provides a clear research agenda for the years to come.1 Mass drug administration (MDA) using ivermectin reduced the prevalence of both scabies and impetigo tremendously in Fiji with a sustained effect even 24 months after the intervention.2 Future studies should prioritise the inclusion of non-island populations.en_US
dc.description.sponsorshipKNUSTen_US
dc.identifier.citationThe Lancet Vol 394en_US
dc.identifier.urihttps://ir.knust.edu.gh/handle/123456789/11923
dc.language.isoenen_US
dc.publisherThe Lanceten_US
dc.titleThe public health control of scabies: priorities for research and actionen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
The public health control of scabies.pdf
Size:
40.63 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
license.txt
Size:
1.73 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Articles